Literature DB >> 33051127

Effective provider-patient communication of a rare disease diagnosis: A qualitative study of people diagnosed with schwannomatosis.

Vanessa L Merker1, Scott R Plotkin2, Martin P Charns3, Mark Meterko4, Justin T Jordan5, A Rani Elwy6.   

Abstract

OBJECTIVE: To understand diagnostic communication preferences of patients with schwannomatosis, a rare disease.
METHODS: Eighteen adults with schwannomatosis from across the United States participated in semi-structured phone interviews about their diagnostic experiences. Interview transcripts were inductively coded using thematic analysis.
RESULTS: We identified three elements of effective diagnostic communication: education (particularly about etiology, prognosis, and treatment options); psychological support (to cope with the new diagnosis and any prior diagnostic harms); and efforts to develop therapeutic alliance (i.e. feelings of collaboration, trust, and social-emotional rapport). Poor communication was characterized by inadequate or jargon-heavy explanations, perceived disinterest in or disbelief of symptoms, and lack of partnership. Effective communication helped people feel informed and cope with their condition; poor communication could cause significant psychological distress.
CONCLUSIONS: During diagnosis, patients need education and psychosocial support; the presence of therapeutic alliance between clinicians and patients facilitates this assistance. Diagnostic communication that includes these elements helps patients proactively engage in healthcare decision-making and connect with appropriate treatments. PRACTICE IMPLICATIONS: When disclosing a rare disease diagnosis, clinicians should meaningfully educate patients about the disorder and acknowledge diagnosis-related psychosocial stressors. Approaching diagnosis empathetically and collaboratively helps foster therapeutic alliance. Referrals for psychological and genetic counseling are often warranted. Published by Elsevier B.V.

Entities:  

Keywords:  Communication; Diagnosis; Doctor-Patient relationships; Qualitative research; Rare diseases

Mesh:

Year:  2020        PMID: 33051127      PMCID: PMC8004534          DOI: 10.1016/j.pec.2020.09.029

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  29 in total

1.  Communicating genetic and genomic information: health literacy and numeracy considerations.

Authors:  D H Lea; K A Kaphingst; D Bowen; I Lipkus; D W Hadley
Journal:  Public Health Genomics       Date:  2010-04-20       Impact factor: 2.000

2.  Creation of an international registry to support discovery in schwannomatosis.

Authors:  K L Ostrow; A L Bergner; J Blakeley; D G Evans; R Ferner; J M Friedman; G J Harris; J T Jordan; B Korf; S Langmead; G Leschziner; V Mautner; V L Merker; L Papi; S R Plotkin; J M Slopis; M J Smith; A Stemmer-Rachamimov; K Yohay; A J Belzberg
Journal:  Am J Med Genet A       Date:  2016-10-19       Impact factor: 2.802

3.  Schwannomatosis: a genetic and epidemiological study.

Authors:  D Gareth Evans; Naomi L Bowers; Simon Tobi; Claire Hartley; Andrew J Wallace; Andrew T King; Simon K W Lloyd; Scott A Rutherford; Charlotte Hammerbeck-Ward; Omar N Pathmanaban; Simon R Freeman; John Ealing; Mark Kellett; Roger Laitt; Owen Thomas; Dorothy Halliday; Rosalie Ferner; Amy Taylor; Chris Duff; Elaine F Harkness; Miriam J Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-06-16       Impact factor: 10.154

4.  Clinical features of schwannomatosis: a retrospective analysis of 87 patients.

Authors:  Vanessa L Merker; Sonia Esparza; Miriam J Smith; Anat Stemmer-Rachamimov; Scott R Plotkin
Journal:  Oncologist       Date:  2012-08-27

5.  Clinical research for rare disease: opportunities, challenges, and solutions.

Authors:  Robert C Griggs; Mark Batshaw; Mary Dunkle; Rashmi Gopal-Srivastava; Edward Kaye; Jeffrey Krischer; Tan Nguyen; Kathleen Paulus; Peter A Merkel
Journal:  Mol Genet Metab       Date:  2008-11-13       Impact factor: 4.797

Review 6.  The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis.

Authors:  Fiona Walter; Andrew Webster; Suzanne Scott; Jon Emery
Journal:  J Health Serv Res Policy       Date:  2011-10-18

7.  Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.

Authors:  Susanne Blöß; Christian Klemann; Ann-Katrin Rother; Sandra Mehmecke; Ulrike Schumacher; Urs Mücke; Martin Mücke; Christiane Stieber; Frank Klawonn; Xiaowei Kortum; Werner Lechner; Lorenz Grigull
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

8.  Using the framework method for the analysis of qualitative data in multi-disciplinary health research.

Authors:  Nicola K Gale; Gemma Heath; Elaine Cameron; Sabina Rashid; Sabi Redwood
Journal:  BMC Med Res Methodol       Date:  2013-09-18       Impact factor: 4.615

9.  Health-related quality of life among adults with diverse rare disorders.

Authors:  Kathleen R Bogart; Veronica L Irvin
Journal:  Orphanet J Rare Dis       Date:  2017-12-07       Impact factor: 4.123

10.  Diagnostic odyssey of patients with mitochondrial disease: Results of a survey.

Authors:  Johnston Grier; Michio Hirano; Amel Karaa; Emma Shepard; John L P Thompson
Journal:  Neurol Genet       Date:  2018-03-26
View more
  2 in total

1.  Mental health care for rare disease in the UK - recommendations from a quantitative survey and multi-stakeholder workshop.

Authors:  Rosa Spencer-Tansley; Nick Meade; Farhana Ali; Amy Simpson; Amy Hunter
Journal:  BMC Health Serv Res       Date:  2022-05-14       Impact factor: 2.908

Review 2.  Current Status of Genetic Counselling for Rare Diseases in Spain.

Authors:  Sara Álvaro-Sánchez; Irene Abreu-Rodríguez; Anna Abulí; Clara Serra-Juhe; Maria Del Carmen Garrido-Navas
Journal:  Diagnostics (Basel)       Date:  2021-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.